Clinical significance of ERβ mRNA expression in ERα-negative and triple-negative breast cancers

被引：0
|
作者：
Kim, Young Choi
Kim, Hadong
Kim, Tae-Hoon
机构：
[1] Yale Univ, Sch Med, Bridgeport, CT USA
[2] Dong A Pharmaceut Co Ltd, Yongin, South Korea
[3] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
545
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PKC alpha and ER beta Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients
    Tonetti, Debra A.
    Gao, Weihua
    Escarzaga, Diana
    Walters, Kelly
    Szafran, April
    Coon, John S.
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
  • [22] Mammographic features of triple-negative versus HER2+ and ER+ breast cancers.
    Yang, W. T.
    Dryden, M.
    Broglio, K.
    Dawood, S.
    Valero, V.
    Hortobagyi, G.
    Atchley, D.
    Arun, B.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S49 - S49
  • [23] Folate Receptor alpha Is Frequently Expressed in ER/PR Negative and Triple Negative Breast Cancers
    Tacha, D.
    Bremer, R.
    [J]. MODERN PATHOLOGY, 2013, 26 : 71A - 71A
  • [24] Folate Receptor alpha Is Frequently Expressed in ER/PR Negative and Triple Negative Breast Cancers
    Tacha, D.
    Bremer, R.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 71A - 71A
  • [25] Filamin-A expression in triple-negative breast cancer and its clinical significance
    Ouban, Abderrahman
    [J]. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2021, 35 (01) : 1409 - 1419
  • [26] Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
    Perez, Edith A.
    Patel, Tejal
    Moreno-Aspitia, Alvaro
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (02) : 261 - 271
  • [27] Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
    Edith A. Perez
    Tejal Patel
    Alvaro Moreno-Aspitia
    [J]. Breast Cancer Research and Treatment, 2010, 121 : 261 - 271
  • [28] Targeting the mTOR/TORC Pathway for the prevention of er-negative and triple-negative breast cancer
    Mazumdar, Abhijit
    Hill, Jamal
    Zhang, Yun
    Bollu, Lakshmi Reddy
    Contreras, Alejandro
    Savage, Michelle
    Sei, Shizuko
    Mohammed, Altaf
    Brown, Powel
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [29] GATA3 expression in triple-negative breast cancers
    Byrne, David J.
    Deb, Siddhartha
    Takano, Elena A.
    Fox, Stephen B.
    [J]. HISTOPATHOLOGY, 2017, 71 (01) : 63 - 71
  • [30] Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes
    Julie A. Y. Billar
    Amylou C. Dueck
    Chee-Chee H. Stucky
    Richard J. Gray
    Nabil Wasif
    Donald W. Northfelt
    Ann E. McCullough
    Barbara A. Pockaj
    [J]. Annals of Surgical Oncology, 2010, 17 : 384 - 390
12345